Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Millar

Showing results (101-110 of 574) with videos related to

Pageof 58
Sort By:
The New Zealand Medical Journal|June 27, 1990
Minimum effective dosage in the drug treatment of hypertensionJ A Millar, H J Waal-Manning
Plants (Basel, Switzerland)|August 2, 2019
Biology and Function of miR159 in PlantsAnthony A Millar, Allan Lohe, Gigi Wong
Frontiers in Plant Science|April 19, 2013
Expression of human ARGONAUTE 2 inhibits endogenous microRNA activity in ArabidopsisIra Deveson, Junyan Li, Anthony A Millar
Internal Medicine Journal|January 11, 2016
Estimation of clinical and economic effects of prophylaxis against venous thromboembolism in medical patients, including the effect of targeting patients at high-riskJ A Millar, A L K Gee
Molecular & Cellular Oncology|December 7, 2017
Some assembly required: Redefining the mitotic checkpointJohn C Meadows, Jonathan B A Millar
Biochemical Society Transactions|January 27, 2015
Sharpening the anaphase switchJohn C Meadows, Jonathan B A Millar
Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology|January 29, 2011
Ringing the changes: emerging roles for DASH at the kinetochore-microtubule InterfaceGraham J Buttrick, Jonathan B A Millar
The New Zealand Medical Journal|February 12, 1992
Current treatment of hypertension. Part 1: Diagnosis and nonpharmacological therapyJ A Millar, H J Waal-Manning
The New Zealand Medical Journal|February 26, 1992
Current treatment of hypertension. Part 2: Risk factors, drug treatment and economic aspectsJ A Millar, H J Waal-Manning
Cell Cycle (Georgetown, Tex.)|April 23, 2016
Mph1/MPS1 checks in at the kinetochoreAmerica Hervas-Aguilar, Jonathan B A Millar
Pageof 58

Showing results (101-110 of 574) with videos related to

Sort By:
Pageof 58
The New Zealand Medical Journal|June 27, 1990
Minimum effective dosage in the drug treatment of hypertensionJ A Millar, H J Waal-Manning
Plants (Basel, Switzerland)|August 2, 2019
Biology and Function of miR159 in PlantsAnthony A Millar, Allan Lohe, Gigi Wong
Frontiers in Plant Science|April 19, 2013
Expression of human ARGONAUTE 2 inhibits endogenous microRNA activity in ArabidopsisIra Deveson, Junyan Li, Anthony A Millar
Internal Medicine Journal|January 11, 2016
Estimation of clinical and economic effects of prophylaxis against venous thromboembolism in medical patients, including the effect of targeting patients at high-riskJ A Millar, A L K Gee
Molecular & Cellular Oncology|December 7, 2017
Some assembly required: Redefining the mitotic checkpointJohn C Meadows, Jonathan B A Millar
Biochemical Society Transactions|January 27, 2015
Sharpening the anaphase switchJohn C Meadows, Jonathan B A Millar
Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology|January 29, 2011
Ringing the changes: emerging roles for DASH at the kinetochore-microtubule InterfaceGraham J Buttrick, Jonathan B A Millar
The New Zealand Medical Journal|February 12, 1992
Current treatment of hypertension. Part 1: Diagnosis and nonpharmacological therapyJ A Millar, H J Waal-Manning
The New Zealand Medical Journal|February 26, 1992
Current treatment of hypertension. Part 2: Risk factors, drug treatment and economic aspectsJ A Millar, H J Waal-Manning
Cell Cycle (Georgetown, Tex.)|April 23, 2016
Mph1/MPS1 checks in at the kinetochoreAmerica Hervas-Aguilar, Jonathan B A Millar
Pageof 58